Bicosome announces new patents for biomimetic skincare platforms

These new lipid gel patents are the result of collaboration between Bicosome and the Institute for Advanced Chemistry of Catalonia (IQAC)

31 of January of 2023
Save
Bicosome
Bicosome

Bicosome announces the in-licensing of two new patents developed in the Institute of Advanced Chemistry of Catalonia (IQAC) from the Spanish National Research Council (CSIC). The new technological platforms, only based on lipids and water, do not need the presence of polymers, surfactants, or other gelling agents, which will bring valuable benefits for skin treatments, especially for sensitive skin.

According to Bicosome Technical Director, Dr. Gelen Rodriguez “The structure and fluidity of the biomimetic gels respond in a reversible way to temperature and pH and their rheological behavior makes them easy to apply topically. These gels will be able to be used at a surface level as a cutaneous acid mantle substitute, protecting the skin as well as acting as a reservoir for target molecules.”

The collaboration between Bicosome and IQAC is based on a decade-long relationship and focused on generating natural, sustainable, and biology-respectful solutions for skin care. Their first collaboration gave rise to the Bicosome dual delivery systems patent, a nanostructured technology that mimics the lamellar bodies' transportation function into target skin layers. This patent generated several products currently in the Bicosome portfolio. The new lipid gel patents are very complementary to the current Bicosome IP in skin delivery. “The unique organization of the biomimetic gels, with part of the water being trapped in a framework of lipid structures, makes these gels very adequate to transport actives of different nature and allows them to be located in different compartments,” said Dr. Olga Lopez, a scientist at IQAC-CSIC and who led the invention.

The gel's exclusive hydrolipidic composition guarantees high biocompatibility and its capacity to respond to biological parameters points to very promising applications in future products. According to Bicosome CEO Dr. Lucyanna Barros, “these new technologies are perfectly in line with the company’s mission to create innovative technologies mimicking skin functions in order to provide customers with sophisticated nature-driven skin delivery solutions.”

Bicosome estimates that the first products with this breakthrough technology will be available for customers in two years.